ICU Medical, Inc. (NASDAQ:ICUI) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 20.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,531 shares of the medical instruments supplier's stock after purchasing an additional 8,789 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.21% of ICU Medical worth $7,996,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Arizona State Retirement System increased its stake in ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after buying an additional 65 shares in the last quarter. Huntington National Bank increased its stake in ICU Medical by 6.2% during the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock worth $218,000 after buying an additional 82 shares in the last quarter. Equitable Trust Co. increased its stake in ICU Medical by 1.6% during the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after buying an additional 84 shares in the last quarter. LPL Financial LLC increased its stake in ICU Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock worth $747,000 after buying an additional 93 shares in the last quarter. Finally, Alliancebernstein L.P. increased its stake in ICU Medical by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock worth $4,051,000 after buying an additional 136 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Price Performance

Shares of ICUI stock traded down $4.32 during trading hours on Monday, reaching $130.54. The company had a trading volume of 213,368 shares, compared to its average volume of 278,224. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The stock has a fifty day moving average of $137.87 and a 200-day moving average of $150.80. The company has a market capitalization of $3.21 billion, a price-to-earnings ratio of -28.56 and a beta of 0.87. ICU Medical, Inc. has a 12-month low of $105.30 and a 12-month high of $196.26.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.49. The company had revenue of $599.49 million during the quarter, compared to analyst estimates of $574.15 million. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. The firm's revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.96 earnings per share. On average, equities analysts anticipate that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Insiders Place Their Bets

In other ICU Medical news, COO Christian B. Voigtlander sold 4,985 shares of the company's stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $128.50, for a total transaction of $640,572.50. Following the transaction, the chief operating officer now directly owns 6,088 shares in the company, valued at $782,308. This represents a 45.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David C. Greenberg sold 1,942 shares of the company's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $143.66, for a total value of $278,987.72. Following the transaction, the director now owns 6,760 shares in the company, valued at $971,141.60. This trade represents a 22.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 36,097 shares of company stock valued at $4,860,156 over the last quarter. 1.50% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on ICUI shares. Wall Street Zen upgraded ICU Medical from a "hold" rating to a "buy" rating in a research note on Sunday, May 18th. KeyCorp cut their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Raymond James dropped their price target on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research report on Friday, May 9th. Finally, Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, ICU Medical presently has a consensus rating of "Buy" and a consensus target price of $192.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.